| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.03B | -38.5% |
| Gross profit | ¥0.01B | — |
| Operating income | ¥-0.00B | — |
| Net income | ¥-0.00B | -166.2% |
| Gross margin | 48.1% | Net margin -13.1% |
| Revenue Q/Q | -51.9% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.01B | 51.9% |
| R&D | ¥0.00B | 14.0% |
| SG&A | ¥0.01B | 28.2% |
| Tax & other | ¥0.00B | 0.1% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
共同药业 ・ 晓鸣股份 ・ 格林精密 ・ 恒帅股份 ・ 华绿生物 ・ 博亚精工 ・ 万辰集团 ・ 立高食品 ・ 商络电子 ・ 达瑞电子 ・ 深圳瑞捷 ・ 东箭科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies